‘Following reports of sunken faces, muscle mass loss and malnutrition with Ozempic, another rare side effect has popped up: severe gastroparesis, or stomach paralysis.
Ozempic, a glucagon-like peptide receptor agonist approved for Type 2 diabetes, works by mimicking GLP-1 to suppress appetite and delay the passage of food in the stomach. Some patients told CNN in a July 25 report they were diagnosed with severe gastroparesis after taking the medication for weight loss. ‘
👀 Popular Weight Loss Drugs May Be Causing 'Stomach Paralysis'
"The FDA has said it's received some reports of stomach paralysis among patients taking the medicines. They don't know if the medicines caused this." pic.twitter.com/yXON1D6fgH
— Chief Nerd (@TheChiefNerd) July 26, 2023
EMA statement on ongoing review of GLP-1 receptor agonists
EMA’s safety committee, the PRAC, is reviewing data on the risk of suicidal thoughts and thoughts of self-harm with medicines known as GLP-1 receptor agonists,1 including Ozempic (semaglutide), Saxenda (liraglutide) and Wegovy (semaglutide). These medicines are used for weight loss and for treating type 2 diabetes.
https://www.ema.europa.eu/en/news/ema-statement-ongoing-review-glp-1-receptor-agonists
h/t A Deplorable Neanderthal